<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref-39">
 <label>39</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gouw</surname>
    <given-names>SC</given-names>
   </name>
   <name>
    <surname>van der Bom</surname>
    <given-names>JG</given-names>
   </name>
   <name>
    <surname>Ljung</surname>
    <given-names>R</given-names>
   </name>
   <etal/>
  </person-group>: 
  <article-title>Factor VIII products and inhibitor development in severe hemophilia A.</article-title>
  <source>
   <italic>N Engl J Med.</italic>
  </source>
  <year>2013</year>;
  <volume>368</volume>(
  <issue>3</issue>):
  <fpage>231</fpage>â€“
  <lpage>9</lpage>. 
  <pub-id pub-id-type="doi">10.1056/NEJMoa1208024</pub-id>
  <?supplied-pmid 23323899?>
  <pub-id pub-id-type="pmid">23323899</pub-id>
 </mixed-citation>
 <note>
  <p>
   <ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/717973234" xmlns:xlink="http://www.w3.org/1999/xlink">F1000 Recommendation</ext-link>
  </p>
 </note>
</ref>
